PMS | 디엔에이테크퍼시픽-DNA TECHNOLOGIES PACIFIC                        
DNA Technologies Pacific

ring_volume  Phone : +82 2 6749-1161

forward_to_inbox  E-mail : info@dna-tec.org

Search in Boards

사이트 내 전체검색

Clinical Research

CS Center

Tel. 02-6749-1161

AM 9:00 ~ PM 6:00

* Saturday,Sunday,Holiday : Days Off

Fax 02.6749.0711
info@dna-tec.org

PMS

What is Post-market surveillance (PMS)?



‘Post-market Surveillance’ means all activities carried out by manufacturers in cooperation with other economic operators to institute and keep up to date a systematic procedure to proactively collect and review experience gained from devices they place on the market, make available on the market or put into service for the purpose of identifying any need to immediately apply any necessary corrective or preventive actions.



What is PMS

  • The following information shall be available through PMS

    -  Information concerning serious incidents, including information from PSURs, and field safety corrective actions
    -  Records referring to non-serious incidents and data on any undesirable side-effects
    -  Information from trend reporting
    -  Relevant specialist or technical literature, databases and/or registers
    -  Information, including feedbacks and complaints, provided by users, distributors and importers
    -  Publicly available information about similar medical devices



Manufacturer’s Obligation for PMS



The manufacturers shall plan, establish, document, implement, maintain and update a post-market surveillance system in a manner that is proportionate to the risk class and appropriate for the type of device. PMS system shall be an integral part of the manufacturer's quality management system.



The post-market surveillance system shall be suited to actively and systematically gathering, recording and analyzing relevant data on the quality, performance and safety of a device throughout its entire lifetime, and to drawing the necessary conclusions and to determining, implementing and monitoring any preventive and corrective actions.



If, in the course of the post-market surveillance, a need for preventive or corrective action or both is identified, the manufacturer shall implement the appropriate measures and inform the competent authorities concerned and, where applicable, the notified body. Where a serious incident is identified or a field safety corrective action is implemented, it shall be reported in accordance with vigilance system.



MDR has increased the post-market requirements for manufacturers and their obligation to proactively collect data and document and report the analysis of these post-market activities and data.



PMS Report by Class



1. Post-Market Surveillance Report(PMSR)
Manufacturers of class I devices shall prepare a post-market surveillance report summarizing the results and conclusions of the analyses of the post-market surveillance data gathered as a result of the post-market surveillance plan together with a rationale and description of any preventive and corrective actions taken. The report shall be updated when necessary and made available to the competent authority upon request.



2. Periodic safety update report(PSUR)
Manufacturers of class IIa, class IIb and class III devices shall prepare a periodic safety update report (‘PSUR’) for each device and where relevant for each category or group of devices summarizing the results and conclusions of the analyses of the post-market surveillance data gathered as a result of the post-market surveillance plan together with a rationale and description of any preventive and corrective actions taken.

DNA TECHNOLOGIES PACIFIC - PMS Service

  • 01DNA Technologies Pacific provides clinical investigation services to obtain PMS data.

  • 02A full guide and technical support are available throughout the PMCF progress, from planning and documentation for the PMCF to clinical investigationthe for European population.

Quick Menu